1-3 of 3
Hongtae Kim
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Novel Microfluidic and AI-Based Approach for Personalized Drug Selection in Chronic Myeloid Leukemia (CML) Patients

Hwisu Jeon, Yukyung Park, Eujin Um, Hongtae Kim, Chang-Yeol Jung, Dong-Wook Kim, Taesung Kim
Journal: Blood
Blood (2024) 144 (Supplement 1): 7482.
https://doi.org/10.1182/blood-2024-199886
Published: 2024
Journal Articles

A More Rapid Initial Decline of BCR::ABL1 Transcripts and Longer Treatment Duration with Improvement of Treatment-Free Remission Rate after Discontinuation of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia

Sewon Lee, Yeung-Chul Mun, Hongtae Kim, Sung-Ho Park, Semin Lee, Seunghoon Kim, Sung-Hyun Kim, Young Rok Do, Soo-Hyun Kim, Kyung-Mi Kee, Yoonsung Lee, Dong-Wook Kim
Journal: Blood
Blood (2024) 144 (Supplement 1): 1779.
https://doi.org/10.1182/blood-2024-199242
Published: 2024
Journal Articles

Improvement of Treatment-Free Remission Rate Following Discontinuation of BCR::ABL1 Tyrosine Kinase Inhibitors in Chronic Phase, Chronic Myeloid Leukemia

Sewon Lee, Hongtae Kim, Semin Lee, Seunghoon Kim, Sung-Ho Park, Sung-Hyun Kim, Young Rok Do, Soo-Hyun Kim, Kyung-Mi Kee, Dong-Wook Kim
Journal: Blood
Blood (2023) 142 (Supplement 1): 1806.
https://doi.org/10.1182/blood-2023-178408
Published: 2023